nach oben

Erschienen in:

10.09.2022 | Annotated Sequence Record

Analysis of the genomic diversity of human papillomavirus type 31 in cervical samples reveals the presence of novel sublineages in clade C

verfasst von: David Esaú Fragoso-Fonseca, Ubaldo Emilio Ruiz-Hernández, Brenda Berenice Trujillo-Salgado, Rita Teresita Manuell-Barrios, Fabiola Garcés-Ayala, Juan Carlos del Mazo-López, Alfonso Méndez-Tenorio, Lucía Hernández-Rivas, José Ernesto Ramírez-González, Noé Escobar-Escamilla

Erschienen in: Archives of Virology | Ausgabe 12/2022

Einloggen, um Zugang zu erhalten

Abstract

Human papillomavirus 31 (HPV31) is the fourth most frequent high-risk HPV (HR-HPV) genotype identified in cervical cancer (CC) worldwide and in Mexico. It has been recently classified into three lineages (A, B, and C) and eight sublineages (A1, A2, B1, B2, and C1 – C4). Here, we report the complete genomic sequences of 14 HPV31 isolates from cervical samples, and these were compared with viral genome sequences from the GenBank database for phylogenetic and genetic distance analysis. The formation of two novel clades within the C lineage (proposed as C5 and C6) was observed, with a well-defined variant-specific mutational pattern. The smallest average pairwise distance was 0.71% for lineages A and B, 0.94% for lineages A and C, and 1.01% for lineages B and C, and between sublineages, these values were 0.21% for clade A, 0.29% for clade B, and 0.24% for clade C. The isolates were grouped into the sublineages A1, B2, C1-C3, and C6. This is the first report on the whole-genome diversity of HPV31 in Mexico.

Nur mit Berechtigung zugänglich

Arroyo Mühr LS, Eklund C, Dillner J (2021) Misclassifications in human papillomavirus databases. Virology 558:57–66. https://doi.org/10.1016/j.virol.2021.03.002CrossRef

Bernard HU, Burk RD, Chen Z, van Doorslaer K, zur Hausen H, de Villiers EM (2010) Classification of papillomaviruses (PVs) based on 189 PV types and proposal of taxonomic amendments. Virology 401(1): 70–79. https://doi.org/10.1016/j.virol.2010.02.002

Brianti P, De Flammineis E, Mercuri SR (2017) Review of HPV-related diseases and cancers. New Microbiol 40(2):80–85

Burk RD, Harari A, Chen Z (2013) Human papillomavirus genome variants. Virology 445(1–2):232–243. https://doi.org/10.1016/j.virol.2013.07.018CrossRef

Calleja-Macias IE, Villa LL, Prado JC, Kalantari M, Allan B, Williamson AL, Chung LP, Collins RJ, Zuna RE, Dunn ST, Chu TY, Cubie HA, Cuschieri K, von Knebel-Doeberitz M, Martins CR, Sanchez GI, Bosch FX, Munoz N, Bernard HU (2005) Worldwide genomic diversity of the high-risk human papillomavirus types 31, 35, 52, and 58, four close relatives of human papillomavirus type 16. J Virol 79(21):13630–13640. https://doi.org/10.1128/JVI.79.21.13630-13640.2005CrossRef

Chen Z, Schiffman M, Herrero R, Desalle R, Anastos K, Segondy M, Sahasrabuddhe VV, Gravitt PE, Hsing AW, Burk RD (2011) Evolution and taxonomic classification of human papillomavirus 16 (HPV16)-related variant genomes: HPV31, HPV33, HPV35, HPV52, HPV58 and HPV67. PLoS ONE 6(5):e20183. https://doi.org/10.1371/journal.pone.0020183CrossRef

Chen Z, Schiffman M, Herrero R, DeSalle R, Anastos K, Segondy M, Sahasrabuddhe VV, Gravitt PE, Hsing AW, Burk RD (2013) Evolution and taxonomic classification of alphapapillomavirus 7 complete genomes: HPV18, HPV39, HPV45, HPV59, HPV68 and HPV70. PLoS ONE 8(8):e72565. https://doi.org/10.1371/journal.pone.0072565CrossRef

Chen Z, Schiffman M, Herrero R, DeSalle R, Anastos K, Segondy M, Sahasrabuddhe VV, Gravitt PE, Hsing AW, Chan P, Burk RD (2018) Classification and evolution of human papillomavirus genome variants: Alpha-5 (HPV26, 51, 69, 82), Alpha-6 (HPV30, 53, 56, 66), Alpha-11 (HPV34, 73), Alpha-13 (HPV54) and Alpha-3 (HPV61). Virology 516:86–101. https://doi.org/10.1016/j.virol.2018.01.002CrossRef

Darriba D, Taboada GL, Doallo R, Posada D (2012) jModelTest 2: more models, new heuristics and parallel computing. Nat Methods 9(8):772. https://doi.org/10.1038/nmeth.2109CrossRef

10.

de Martel C, Plummer M, Vignat J, Franceschi S (2017) Worldwide burden of cancer attributable to HPV by site, country and HPV type. Int J Cancer 141(4):664–670. https://doi.org/10.1002/ijc.30716CrossRef

11.

de Sanjose S, Quint WG, Alemany L, Geraets DT, Klaustermeier JE, Lloveras B, Tous S, Felix A, Bravo LE, Shin HR, Vallejos CS, de Ruiz PA, Lima MA, Guimera N, Clavero O, Alejo M, Llombart-Bosch A, Cheng-Yang C, Tatti SA, Kasamatsu E Retrospective International Survey and HPV Time Trends Study Group (2010) Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study The Lancet. Oncology 11(11): 1048–1056. https://doi.org/10.1016/S1470-2045(10)70230-8

12.

Escobar-Escamilla N, Ramírez-González JE, Castro-Escarpulli G, Díaz-Quiñonez JA (2018) Utility of high-throughput DNA sequencing in the study of the human papillomaviruses. Virus Genes 54(1):17–24. https://doi.org/10.1007/s11262-017-1530-3CrossRef

13.

Ferlay J, Ervik M, Lam F, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2020) Global Cancer Observatory: Cancer Today. Lyon, France: Int Agency Res Cancer. Available from: https://gco.iarc.fr/today, Accessed March 2022.

14.

International Human Papillomavirus (HPV) Reference Center. Available at https://www.hpvcenter.se/ Accessed February 2022

15.

Institute of Oncology (ICO) and the International Agency for Research on Cancer (IARC) Information Centre on HPV and Cancer. (2021) Human Papillomavirus and Related Cancers, Fact Sheet 2021, Mexico. Available at https://hpvcentre.net/statistics/reports/MEX_FS.pdf Accessed February 2022

16.

Kozlov AM, Darriba D, Flouri T, Morel B, Stamatakis A (2019) RAxML-NG: a fast, scalable and user-friendly tool for maximum likelihood phylogenetic inference. Bioinformatics (Oxford, England) 35(21):4453–4455. https://doi.org/10.1093/bioinformatics/btz305CrossRef

17.

Latsuzbaia A, Wienecke-Baldacchino A, Tapp J, Arbyn M, Karabegović I, Chen Z, Fischer M, Mühlschlegel F, Weyers S, Pesch P, Mossong J (2020) Characterization and diversity of 243 complete Human papillomavirus genomes in cervical swabs using next generation sequencing. Viruses 12(12):1437. https://doi.org/10.3390/v12121437CrossRef

18.

Okonechnikov K, Golosova O, Fursov M, Varlamov A, Vaskin Y, Efremov I, German Grehov OG, Kandrov D, Rasputin K, Syabro M, Tleukenov T (2012) Unipro UGENE: A unified bioinformatics toolkit. Bioinformatics 28(8):1166–1167. https://doi.org/10.1093/bioinformatics/bts091CrossRef

19.

Ou Z, Chen Z, Zhao Y, Lu H, Liu W, Li W, Ren P, Geng C, Xiao M, Hu G, Wu D, Wang X, Liu N, Zhu S, Lu L, Li J (2021) Genetic signatures for lineage/sublineage classification of HPV16, 18, 52 and 58 variants. Virology 553:62–69. https://doi.org/10.1016/j.virol.2020.11.003CrossRef

20.

Pinheiro M, Harari A, Schiffman M, Clifford GM, Chen Z, Yeager M, Cullen M, Boland JF, Raine-Bennett T, Steinberg M, Bass S, Xiao Y, Tenet V, Yu K, Zhu B, Burdett L, Turan S, Lorey T, Castle PE, Wentzensen N, Mirabello L (2021) Phylogenomic analysis of Human papillomavirus type 31 and cervical carcinogenesis: a study of 2093 viral genomes. Viruses 13(10):1948. https://doi.org/10.3390/v13101948CrossRef

21.

Pinheiro M, Gage JC, Clifford GM, Demarco M, Cheung LC, Chen Z, Yeager M, Cullen M, Boland JF, Chen X, Raine-Bennett T, Steinberg M, Bass S, Befano B, Xiao Y, Tenet V, Walker J, Zuna R, Poitras NE, Gold MA, Mirabello L (2020) Association of HPV35 with cervical carcinogenesis among women of African ancestry: Evidence of viral-host interaction with implications for disease intervention. Int J Cancer 147(10):2677–2686. https://doi.org/10.1002/ijc.33033CrossRef

22.

Smith JS, Lindsay L, Hoots B, Keys J, Franceschi S, Winer R, Clifford GM (2007) Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: a meta-analysis update. Int J Cancer 121(3):621–632. https://doi.org/10.1002/ijc.22527CrossRef

23.

Untergasser A, Nijveen H, Rao X, Bisseling T, Geurts R, Leunissen JA (2007) Primer3Plus, an enhanced web interface to Primer3. Nucleic acids Res 35(Web Server issue), W71–W74. https://doi.org/10.1093/nar/gkm306

24.

Van Doorslaer K, Li Z, Xirasagar S, Maes P, Kaminsky D, Liou D, Sun Q, Kaur R, Huyen Y, McBride AA (2017) The Papillomavirus Episteme: a major update to the papillomavirus sequence database. Nucleic Acids Res 45(D1):D499–D506. https://doi.org/10.1093/nar/gkw879CrossRef

25.

Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, Snijders PJ, Peto J, Meijer CJ, Muñoz N (1999) Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 189(1):12–19. https://doi.org/10.1002/(SICI)1096-9896(199909)189:1%3c12::AID-PATH431%3e3.0.CO;2-FCrossRef

26.

Wilgenbusch JC, Swofford D (2003) Inferring evolutionary trees with PAUP*. Curr Protocols Bioinform Chapter 6. https://doi.org/10.1002/0471250953.bi0604s00CrossRef

Titel: Analysis of the genomic diversity of human papillomavirus type 31 in cervical samples reveals the presence of novel sublineages in clade C
verfasst von: David Esaú Fragoso-Fonseca
Ubaldo Emilio Ruiz-Hernández
Brenda Berenice Trujillo-Salgado
Rita Teresita Manuell-Barrios
Fabiola Garcés-Ayala
Juan Carlos del Mazo-López
Alfonso Méndez-Tenorio
Lucía Hernández-Rivas
José Ernesto Ramírez-González
Noé Escobar-Escamilla
Publikationsdatum: 10.09.2022
Verlag: Springer Vienna
Erschienen in: Archives of Virology / Ausgabe 12/2022
Print ISSN: 0304-8608
Elektronische ISSN: 1432-8798
DOI: https://doi.org/10.1007/s00705-022-05589-2

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Mehr Lebenszeit mit Abemaciclib bei fortgeschrittenem Brustkrebs?

24.05.2024 Mammakarzinom Nachrichten

In der MONARCHE-3-Studie lebten Frauen mit fortgeschrittenem Hormonrezeptor-positivem, HER2-negativem Brustkrebs länger, wenn sie zusätzlich zu einem nicht steroidalen Aromatasehemmer mit Abemaciclib behandelt wurden; allerdings verfehlte der numerische Zugewinn die statistische Signifikanz.

ADT zur Radiatio nach Prostatektomie: Wenn, dann wohl länger

24.05.2024 Prostatakarzinom Nachrichten

Welchen Nutzen es trägt, wenn die Strahlentherapie nach radikaler Prostatektomie um eine Androgendeprivation ergänzt wird, hat die RADICALS-HD-Studie untersucht. Nun liegen die Ergebnisse vor. Sie sprechen für länger dauernden Hormonentzug.

„Überwältigende“ Evidenz für Tripeltherapie beim metastasierten Prostata-Ca.

22.05.2024 Prostatakarzinom Nachrichten

Patienten mit metastasiertem hormonsensitivem Prostatakarzinom sollten nicht mehr mit einer alleinigen Androgendeprivationstherapie (ADT) behandelt werden, mahnt ein US-Team nach Sichtung der aktuellen Datenlage. Mit einer Tripeltherapie haben die Betroffenen offenbar die besten Überlebenschancen.

So sicher sind Tattoos: Neue Daten zur Risikobewertung

22.05.2024 Melanom Nachrichten

Das größte medizinische Problem bei Tattoos bleiben allergische Reaktionen. Melanome werden dadurch offensichtlich nicht gefördert, die Farbpigmente könnten aber andere Tumoren begünstigen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Die Highlights vom Kongress des American College of Cardiology 2024

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 12/2022

Molecular identification and phylogenetic characterization of A-strain isolates of maize streak virus from western Ethiopia

Host adaptation of codon usage in SARS-CoV-2 from mammals indicates potential natural selection and viral fitness

Characterization of Solenopsis invicta virus 4, a polycipivirus infecting the red imported fire ant Solenopsis invicta

Discovery of three cycloviruses in fecal samples from silver-haired bats (Lasionycteris noctivagans) in Arizona (USA)

Structural aspects of hepatitis E virus

Prevalence of hepatitis C virus infection in patients with end-stage renal disease in Latin America and the Caribbean: a systematic review and meta-analysis